IMCR
Immunocore Holdings Ltd
NASDAQ: IMCR · HEALTHCARE · BIOTECHNOLOGY
$27.92
-3.02% today
Updated 2026-04-29
Market cap
$1.42B
P/E ratio
—
P/S ratio
3.55x
EPS (TTM)
$-0.71
Dividend yield
—
52W range
$27 – $41
Volume
0.4M
WallStSmart proprietary scores
43
out of 100
Grade: D
Sell
Investment rating
9.3
Growth
A+5.0
Quality
C+2.5
Profitability
F5.3
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$63.86
+128.72%
12-Month target
—
—
Intrinsic (DCF)
$33.76
Margin of safety
+2.46%
1 Strong Buy10 Buy4 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 24.30% QoQ
Risks
- Thin margins at -8.88%
- Negative free cash flow $-35.53M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $144.23M | $197.39M | $247.98M | $297.57M | $400.02M |
| Net income | $-43.46M | $-43.75M | $-40.81M | $-26.42M | $-22.28M |
| EPS | — | — | — | — | $-0.71 |
| Free cash flow | $-51.41M | $-1.97M | $20.89M | $-11.20M | $-35.53M |
| Profit margin | -30.13% | -22.17% | -16.45% | -8.88% | -8.88% |
Peer comparison
Smart narrative
Immunocore Holdings Ltd trades at $27.92. Our Smart Value Score of 43/100 indicates the stock is fair. TTM revenue stands at $400.02M. with profit margins at -8.88%. Our DCF model estimates intrinsic value at $33.76.
Frequently asked questions
What is Immunocore Holdings Ltd's stock price?
Immunocore Holdings Ltd (IMCR) trades at $27.92.
Is Immunocore Holdings Ltd overvalued?
Smart Value Score 43/100 (Grade D, Sell). DCF value $33.76.
What is the price target of Immunocore Holdings Ltd (IMCR)?
The analyst target price is $63.86, representing +128.7% upside from the current price of $27.92.
What is the intrinsic value of Immunocore Holdings Ltd (IMCR)?
Based on our DCF model, intrinsic value is $33.76, a +2.5% margin of safety versus $27.92.
What is Immunocore Holdings Ltd's revenue?
TTM revenue is $400.02M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio3.55x
ROE-9.58%
Beta0.83
50D MA$31.19
200D MA$33.57
Shares out0.05B
Float0.05B
Short ratio—
Avg volume0.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—